Second patient cured of HIV, say doctors

A man from London has become the second person in the world to be cured of HIV, doctors say.

Adam Castillejo is still free of the virus more than 30 months after stopping anti-retroviral therapy.

He was not cured by the HIV drugs, however, but by a stem-cell treatment, he received for cancer he also had, the Lancet HIV journal reports.

The donors of those stem cells have an uncommon gene that gives them, and now Mr Castillejo, protection against HIV.

In 2011, Timothy Brown, the “Berlin Patient” became the first person reported as cured of HIV, three and half years after having similar treatment.

What is the treatment?

Stem-cell transplants appear to stop the virus being able to replicate inside the body by replacing the patient’s own immune cells with donor ones that resist HIV infection.

Adam Castillejo – the now 40-year-old “London Patient” who has decided to go public with his identity – has no detectable active HIV infection in his blood, semen or tissues, his doctors say.

It is now a year after they first announced he was clear of the virus and he still remains free of HIV.

Lead researcher Prof Ravindra Kumar Gupta, from the University of Cambridge, told BBC News: “This represents HIV cure with almost certainty.

“We have now had two and a half years with anti-retroviral-free remission.

“Our findings show that the success of stem-cell transplantation as a cure for HIV, first reported nine years ago in the Berlin Patient, can be replicated.”

But it will not be a treatment for the millions of people around the world living with HIV.

The aggressive therapy was primarily used to treat the patients’ cancers, not their HIV.

And current HIV drugs remain very effective, meaning people with the virus can live long and healthy lives.

Prof Gupta said: “It is important to note that this curative treatment is high-risk and only used as a last resort for patients with HIV who also have life-threatening haematological malignancies.

“Therefore, this is not a treatment that would be offered widely to patients with HIV who are on successful anti-retroviral treatment.”

But it might offer hope of finding a cure, in the future, using gene therapy.

How does it work?

CCR5 is the most commonly used receptor by HIV-1 – the virus strain of HIV that dominates around the world – to enter cells.

But a very small number of people who are resistant to HIV have two mutated copies of the CCR5 receptor.

This means the virus cannot penetrate cells in the body it normally infects.

Researchers say it may be possible to use gene therapy to target the CCR5 receptor in people with HIV.

It is the same receptor the now jailed Chinese scientist He Jiankui worked on when he created the world’s first gene-edited babies.

Is it a permanent cure?

The tests suggest 99% of Mr Castillejo’s immune cells have been replaced by donor ones.

But he still has remnants of the virus in his body, as does Mr Brown.

And it is impossible to say with absolute certainty his HIV will never come back.

Mr Castillejo told the New York Times: “This is a unique position to be in, a unique and very humbling position.

“I want to be an ambassador of hope.

“I don’t want people to think, ‘Oh, you’ve been chosen.’

“No, it just happened.

“I was in the right place, probably at the right time, when it happened.”

Prof Sharon Lewin, from the University of Melbourne, Australia, said: “Given the large number of cells sampled here and the absence of any intact virus, is the London Patient truly cured?

“The additional data provided in this follow-up case report is certainly encouraging but unfortunately, in the end, only time will tell.”

-BBC

ABOUT: Nana Kwesi Coomson

[email protected]

An Entrepreneur, Corporate Social Responsibility, Corporate Communications Executive and Philanthropist. Editor-in-Chief of www.233times.com. A Senior Journalist with Ghanaian Chronicle Newspaper. An alumnus of Adisadel College where he read General Arts. His first degree is in Bachelor of Arts - Political Science (major) and History (minor) from the University of Ghana. He holds MSc in Corporate Social Responsibility (CSR) and Energy with Public Relations (PR) from the Robert Gordon University in the United Kingdom. He is a 2018 Mandela Washington Fellow who studied at Clark Atlanta University in USA on the Business and Entrepreneurship track.

View all posts by: Nana Kwesi Coomson  

Leave a Reply

Your email address will not be published. Required fields are marked *

ABOUT 233TIMES

233times is a Ghanaian media house which serves as a major source of exclusive interviews ,music and video downloads, news and more.

233times reports on major events,news covering entertainment, politics, sports, business, technology, etc from within Ghana, Africa and beyond.

We have a platform for the amateur artistes to portray their staggering talents ...more...

CONTACT US

For further enquiries, please contact us via our contact us page link: CONTACT

WE ON SOCIAL MEDIA. FOLLOW US


To advertise with us or make enquiries, please visit 233times.net/advertise or call Selorm (Selorm) | Selorm (Nana Kwesi)